Ipca Laboratories zooms despite getting VAI classification for Madhya Pradesh facility

23 Oct 2023 Evaluate

Ipca Laboratories is currently trading at Rs. 997.50, up by 61.30 points or 6.55% from its previous closing of Rs. 936.20 on the BSE.

The scrip opened at Rs. 960.05 and has touched a high and low of Rs. 1008.90 and Rs. 960.05 respectively. So far 138165 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1008.90 on 23-Oct-2023 and a 52 week low of Rs. 670.00 on 22-May-2023.

Last one week high and low of the scrip stood at Rs. 1008.90 and Rs. 933.55 respectively. The current market cap of the company is Rs. 25328.56 crore.

The promoters holding in the company stood at 46.29%, while Institutions and Non-Institutions held 44.91% and 8.81% respectively.

Ipca Laboratories has received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its Ratlam, Madhya Pradesh manufacturing facility. USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023. This facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).  

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.

Ipca Laboratories Share Price

1289.55 -47.90 (-3.58%)
07-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.15
Dr. Reddys Lab 6277.10
Cipla 1388.00
Zydus Lifesciences 980.65
Lupin 1610.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.